Oncology - European Medical Journal

Continue

Oncology

Filter
6 Mins
13 Jun 2019

A New Twist to Ibuprofen: Alternative Action in Alternative Splicing

Ibuprofen belongs to the group of nonsteroidal anti-inflammatory drugs (NSAID) used to treat diverse inflammatory processes, pain, or fever…
11 Mins
13 Jun 2019

The Heart of the Matter: A Unique Convergence of Cardiac Neoplasm, Hereditary Nonpolyposis Colorectal Cancer, and Spindle Cell Sarcoma

Cardiac tumours are rare, with their incidence estimated between 0.0017–0.2800%,1 and the vast majority are metastatic lesions…
9 Mins
13 Jun 2019

Obesity and the Effects of Weight Reduction: A Spotlight on Women with Hormone Receptor-Positive Breast Cancer and Heart Disease

There is a connection between increased body mass, or adipose tissue, and higher risk of developing cancer, particularly in hormone-stimulated neoplastic…
11 Mins
20 May 2019

A Review of Gene Expression Profiling in Early-Stage ER+/HER2- Breast Cancer With A Focus on The PAM50 Risk of Recurrence Assay

Over 70% of patients with early-stage breast cancer are diagnosed with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative…
13 Mins
14 Mar 2019

MET Inhibition in Non-Small Cell Lung Cancer

There has been a decrease in the number of incidences of lung cancer recorded among men over the past few decades as well as among women…
2 Mins
11 Feb 2019

World Cancer Day Message: Cancer Awareness and Empowerment – Every citizen should act as an ambassador!

Whoever you are, you have the power to reduce the impact of cancer for yourself, the people you love, and for the world. It’s time to make a personal…
16 Mins
13 Dec 2018

iBiopsy® for Precision Medicine

A high-throughput artificial intelligence-powered image-based phenotyping platform, iBiopsy® (Median Technologies, Valbonne, France), which aims to…
9 Mins
6 Dec 2018

The Right Therapy Starts with the Right Test: Novel Therapeutic Approaches in Oncology Foster the Need for an Appropriate Molecular Profiling Strategy

Adding a molecular perspective to the traditional multidisciplinary management of cancer patients is substantially hampering the adoption of precision…